{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-005618","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.539169+00:00","generated_at":"2026-06-20T17:12:51.727905+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Werewolf Therapeutics reports 34,275,321 shares outstanding as of Jan 10, 2023","bullets":["Common shares outstanding: 34,275,321 as of January 10, 2023.","Trading symbol: HOWL on Nasdaq Global Select Market.","No financial results or operational updates provided in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-005618","json":"https://secwatch.observer/filing/0001193125-23-005618.json","markdown":"https://secwatch.observer/filing/0001193125-23-005618.md","text":"https://secwatch.observer/filing/0001193125-23-005618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000119312523005618/0001193125-23-005618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000119312523005618/d387828d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:12:51.727905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}